Shares of La Jolla Pharmaceutical Co. (LJPC) climbed more than 76% on Monday, following positive results from its phase III trial of LJPC-501 in patients with catecholamine resistant hypotension.
from RTT - Biotech http://ift.tt/2lj5tkl
via IFTTT
No comments:
Post a Comment